scholarly journals Cloning, expression and characterization of SeM protein of Streptococcus equi subsp. equi and evaluation of its use as antigen in an indirect ELISA

2014 ◽  
Vol 66 (4) ◽  
pp. 1015-1022 ◽  
Author(s):  
C.M. Moraes ◽  
F.R. Conceição ◽  
A.S.R. Rocha ◽  
A.G. Santos Júnior ◽  
L.M. Ribas ◽  
...  
Keyword(s):  
Immune Status ◽  
Indirect Elisa ◽  
High Specificity ◽  
Disease Diagnosis ◽  
Bacterial Isolation ◽  
Serum Samples ◽  
Gene Encoding ◽  
Specificity And Sensitivity ◽  
Streptococcus Equi

Strangles is an economically important horse disease caused by Streptococcus equi subsp. equi. The diagnosis can be confirmed either directly by bacterial isolation and PCR or by ELISA, which is an indirect method based on the detection of serum antibodies. The aim of this study was to clone, express and characterize the SeM protein of Streptococcus equi subsp. equi, evaluate its use as antigen in indirect ELISA and determine its performance to distinguish sera of negative, vaccinated and positive animals. This was initially performed by cloning the gene encoding the SeM protein and its expression in Escherichia coli. Subsequently, the protein produced was characterized and used as antigen in ELISA. Serum samples for evaluation were taken from 40 negative foals, 46 horses vaccinated with a commercial vaccine against strangles and 46 horses diagnosed with the disease. The test showed high specificity and sensitivity, allowing discrimination between negative and positive, positive and vaccinated animals, and vaccinated animals and negative sera. Thus, it was concluded that the protein produced rSeM, which can be used as antigen for disease diagnosis, and the described ELISA might be helpful to evaluate the immune status of the herd.

scholarly journals Serum MicroRNA Signature as a Diagnostic and Therapeutic Marker in Patients with Psoriatic Arthritis

2020 ◽  
Vol 47 (12) ◽  
pp. 1760-1767
Author(s):  
Sarah M. Wade ◽  
Trudy McGarry ◽  
Siobhan C. Wade ◽  
Ursula Fearon ◽  
Douglas J. Veale
Keyword(s):  
Psoriatic Arthritis ◽  
Characteristic Curve ◽  
High Specificity ◽  
Serum Samples ◽  
Rna Molecules ◽  
Serum Mirna ◽  
Serum Microrna ◽  
Specificity And Sensitivity ◽  
European League Against Rheumatism ◽  
Noninvasive Markers

ObjectiveMicroRNA (miRNA) are small endogenous regulatory RNA molecules that have emerged as potential therapeutic targets and biomarkers in autoimmunity. Here, we investigated serum miRNA levels in patients with psoriatic arthritis (PsA) and further assessed a serum miRNA signature in therapeutic responder versus nonresponder PsA patients.MethodsSerum samples were collected from healthy controls (HC; n = 20) and PsA patients (n = 31), and clinical demographics were obtained. To examine circulatory miRNA in serum from HC and PsA patients, a focused immunology miRNA panel was analyzed utilizing a miRNA Fireplex assay (FirePlex Bioworks Inc.). MiRNA expression was further assessed in responders versus nonresponders according to the European League Against Rheumatism response criteria.ResultsSix miRNA (miR-221-3p, miR-130a-3p, miR-146a-5p, miR-151-5p, miR-26a-5p, and miR-21-5p) were significantly higher in PsA compared to HC (all P < 0.05), with high specificity and sensitivity determined by receiver-operating characteristic curve analysis. Analysis of responder versus nonresponders demonstrated higher baseline levels of miR-221-3p, miR-130a-3p, miR-146a-5p, miR-151-5p, and miR-26a-5p were associated with therapeutic response.ConclusionThis study identified a 6-serum microRNA signature that could be attractive candidates as noninvasive markers for PsA and may help to elucidate the disease pathogenesis.

scholarly journals Crude antigen from Taenia crassiceps cysticercus used as heterologous antigen in ELISA and in EITB for neurocysticercosis diagnosis of patients from Paraná-Brazil

2008 ◽  
Vol 51 (6) ◽  
pp. 1127-1137 ◽  
Author(s):  
João Carlos Minozzo ◽  
Juliana de Moura ◽  
Sérgio Monteiro Almeida ◽  
Vanete Thomaz-Soccol
Keyword(s):  
Public Health ◽  
Neurological Disorders ◽  
Indirect Elisa ◽  
Taenia Solium ◽  
High Specificity ◽  
Heterologous Antigen ◽  
Public Health Systems ◽  
Crude Antigen ◽  
Specificity And Sensitivity ◽  
Cysticercus Cellulosae

Neurocysticercosis (NCC), the cerebral presence of Taenia solium metacestode (Cysticercus cellulosae), is responsible for neurological disorders worldwide. In order to validate an immunodiagnosis for public-health patients in the State of Parana-Brazil, crude antigen of Taenia crassicepsmetacestode (Cysticercus longicollis) was used as an alternative heterologous antigen to be used in ELISA and in electroimmunotransfer blotting (EITB) for active and inactive NCC diagnosis. Indirect ELISA was able to discriminate between active and inactive samples and presented high specificity and sensitivity. Any immunodominant band was able to distinguish the NCC stages, although the EITB showed 100% specificity. The immunological results proved to be an important auxiliary toll for NCC diagnosis, mainly for public-health systems in developing countries, where either the neuroimage techniques are not accessible or the resources are scarce.

scholarly journals In-house ELISA method to analyze anti-Trypanosoma cruzi IgG reactivity for differential diagnosis and evaluation of Chagas disease morbidity

2012 ◽  
Vol 45 (1) ◽  
pp. 35-44 ◽  
Author(s):  
Lilian da Silva Santos ◽  
Rosália Morais Torres ◽  
Girley Francisco Machado-de-Assis ◽  
Maria Terezinha Bahia ◽  
Helen Rodrigues Martins ◽  
...  
Keyword(s):  
Differential Diagnosis ◽  
Chagas Disease ◽  
Clinical Status ◽  
High Specificity ◽  
Disease Diagnosis ◽  
Cross Reactivity ◽  
Serological Method ◽  
Serum Dilution ◽  
Specificity And Sensitivity ◽  
American Tegumentary Leishmaniasis

INTRODUCTION: The goal was to develop an in-house serological method with high specificity and sensitivity for diagnosis and monitoring of Chagas disease morbidity. METHODS: With this purpose, the reactivities of anti-T. cruzi IgG and subclasses were tested in successive serum dilutions of patients from Berilo municipality, Jequitinhonha Valley, Minas Gerais, Brazil. The performance of the in-house ELISA was also evaluated in samples from other relevant infectious diseases, including HIV, hepatitis C (HCV), syphilis (SYP), visceral leishmaniasis (VL), and American tegumentary leishmaniasis (ATL), and noninfected controls (NI). Further analysis was performed to evaluate the applicability of this in-house methodology for monitoring Chagas disease morbidity into three groups of patients: indeterminate (IND), cardiac (CARD), and digestive/mixed (DIG/Mix), based on their clinical status. RESULTS: The analysis of total IgG reactivity at serum dilution 1:40 was an excellent approach to Chagas disease diagnosis (100% sensitivity and specificity). The analysis of IgG subclasses showed cross-reactivity, mainly with NI, VL, and ATL, at all selected serum dilutions. Based on the data analysis, the IND group displayed higher IgG3 levels and the DIG/Mix group presented higher levels of total IgG as compared with the IND and CARD groups. CONCLUSIONS: These findings demonstrated that methodology presents promising applicability in the analysis of anti-T. cruzi IgG reactivity for the differential diagnosis and evaluation of Chagas disease morbidity.

scholarly journals INDIRECT ELISA FOR DETECTION OF ANTIBODIES TO FMDV NON-STRUCTURAL PROTEINS IN PORCINE SERA

2018 ◽  
pp. 13-20
Author(s):  
A. S. Yakovleva ◽  
A. V. Kanshina ◽  
A. V. Scherbakov
Keyword(s):  
Indirect Elisa ◽  
High Sensitivity ◽  
High Specificity ◽  
Structural Proteins ◽  
Post Inoculation ◽  
Nonstructural Proteins ◽  
Diagnostic Specificity ◽  
Fmd Virus ◽  
Specificity And Sensitivity ◽  
Sensitivity Specificity

An indirect variant of ELISA used for detection of antibodies to nonstructural proteins of the FMD virus in porcine blood sera was developed. The results of the validation showed that the developed method is characterized by high sensitivity, specificity and reproducibility. When testing the blood serum panel obtained from experimentally infected animals, the method allowed to detect antibodies to FMD virus in 7 of 18 sera collected on day 6 post inoculation, in 13 of 19 sera – on day 7 post inoculation, in 16 of 19 sera – on day 8 post inoculation and in all 76 sera obtained on days 9–12 post inoculation. The diagnostic specificity of 3AB-ELISA was 100% when testing 100 knowingly negative blood sera from pigs imported to Russia from Norway. High specificity and sensitivity of the method, established during the development of the method, are confirmed in the course of routine diagnostic tests.

scholarly journals Recent Progress in Nanomaterials Modified Electrochemical Biosensors for the Detection of MicroRNA

Micromachines ◽  
2021 ◽  
Vol 12 (11) ◽  
pp. 1409
Author(s):  
Sze Shin Low ◽  
Daizong Ji ◽  
Wai Siong Chai ◽  
Jingjing Liu ◽  
Kuan Shiong Khoo ◽  
...  
Keyword(s):  
Electrochemical Biosensor ◽  
Sequence Similarity ◽  
Low Cost ◽  
High Specificity ◽  
Disease Diagnosis ◽  
Electrochemical Biosensors ◽  
High Sequence Similarity ◽  
Aberrant Expression ◽  
Specificity And Sensitivity ◽  
Different Types

MicroRNAs (miRNAs) are important non-coding, single-stranded RNAs possessing crucial regulating roles in human body. Therefore, miRNAs have received extensive attention from various disciplines as the aberrant expression of miRNAs are tightly related to different types of diseases. Furthermore, the exceptional stability of miRNAs has presented them as biomarker with high specificity and sensitivity. However, small size, high sequence similarity, low abundance of miRNAs impose difficulty in their detection. Hence, it is of utmost importance to develop accurate and sensitive method for miRNA biosensing. Electrochemical biosensors have been demonstrated as promising solution for miRNA detection as they are highly sensitive, facile, and low-cost with ease of miniaturization. The incorporation of nanomaterials to electrochemical biosensor offers excellent prospects for converting biological recognition events to electronic signal for the development of biosensing platform with desired sensing properties due to their unique properties. This review introduces the signal amplification strategies employed in miRNA electrochemical biosensor and presents the feasibility of different strategies. The recent advances in nanomaterial-based electrochemical biosensor for the detection of miRNA were also discussed and summarized based on different types of miRNAs, opening new approaches in biological analysis and early disease diagnosis. Lastly, the challenges and future prospects are discussed.

scholarly journals Evaluation of SARS-CoV-2 Antibody Point of Care Devices in the Laboratory and Clinical Setting

2021 ◽  
Author(s):  
Kirsty McCance ◽  
Helen Wise ◽  
Jennifer Simpson ◽  
Becky Bachelor ◽  
Harriet Hale ◽  
...  
Keyword(s):  
Immune Status ◽  
Point Of Care ◽  
Capillary Blood ◽  
Serum Samples ◽  
Specificity And Sensitivity ◽  
Independent Evaluation ◽  
Positive Antibody ◽  
Antibody Titres ◽  
Paired Serum ◽  
Antibody Tests

SARS-CoV-2 Antibody tests have been marketed to diagnose previous SARS-CoV-2 infection and as a test of immune status. There is a lack of evidence on the performance and clinical utility of these tests. We aimed to carry out an evaluation of 14 point of care (POC) SARS-CoV-2 antibody tests. Serum from participants with previous RT-PCR (Real-Time Polymerase chain reaction) confirmed SARS-CoV-2 infection and pre-pandemic controls were used to determine specificity and sensitivity of each POC device. Changes in sensitivity with increasing time from infection were determined on a cohort of participants. Corresponding neutralising antibody status was measured to establish whether the detection of antibodies by the POC device correlated with immune status. Paired capillary and serum samples were collected to ascertain whether POC devices performed comparably on capillary samples. Sensitivity and specificity varied between the POC devices and in general did not meet the manufacturers reported performance characteristics signifying the importance of independent evaluation of these tests. The sensitivity peaked at >20 days following symptoms onset however sensitivity of 3 POC devices evaluated at extended time points showed that sensitivity declined with time and this was particularly marked at >140 days post infection onset. This is relevant if the tests are to be used for sero-prevelence studies. Neutralising antibody data showed positive antibody results on POC devices did not necessarily confer high neutralising antibody titres and these POC devices cannot be used to determine immune status to the SARS-CoV-2 virus. Comparison of paired serum and capillary results showed that there was a decline in sensitivity using capillary blood. This has implications in the utility of the test as they are designed to be used on capillary blood by the general population.

scholarly journals Evaluation of SARS-CoV-2 Neutralizing Antibodies Using a Vesicular Stomatitis Virus Possessing SARS-CoV-2 Spike Protein

2020 ◽  
Author(s):  
Hideki Tani ◽  
Long Tan ◽  
Miyuki Kimura ◽  
Yoshihiro Yoshida ◽  
Hiroshi Yamada ◽  
...  
Keyword(s):  
Virus Infection ◽  
Whole Blood ◽  
Neutralizing Antibodies ◽  
High Specificity ◽  
Immunofluorescence Assay ◽  
Hospitalized Patients ◽  
Pseudotyped Virus ◽  
Serum Samples ◽  
Live Virus ◽  
Specificity And Sensitivity

Abstract Background:SARS-CoV-2 is a novel coronavirus that emerged in 2019 and is now classified in the genus Coronavirus with closely related SARS-CoV. SARS-CoV-2 is highly pathogenic in humans and is classified as a biosafety level (BSL)-3 pathogen, which makes manipulating it relatively difficult due to its infectious nature. Methods:To circumvent the need for BSL-3 laboratories, an alternative assay was developed that avoids live virus and instead uses a recombinant VSV expressing luciferase and possesses the full length or truncated spike proteins of SARS-CoV-2. Furthermore, to measure SARS-CoV-2 neutralizing antibodies under BSL2 conditions, a chemiluminescence reduction neutralization test (CRNT) for SARS-CoV-2 was developed. The neutralization values of the serum samples collected from hospitalized patients with COVID-19 or SARS-CoV-2 PCR-negative donors against the pseudotyped virus infection evaluated by the CRNT were compared with antibody titers determined from an immunofluorescence assay (IFA). Results:The CRNT, which used whole blood collected from hospitalized patients with COVID-19, was also examined. As a result, the inhibition of pseudotyped virus infection was specifically observed in both serum and whole blood and was also correlated with the results of the IFA. Conclusions:In conclusion, the CRNT for COVID-19 is a convenient assay system that can be performed in a BSL-2 laboratory with high specificity and sensitivity for evaluating the occurrence of neutralizing antibodies against SARS-CoV-2.

Standardization and application of rapid tests viz dot ELISA and vertical flow through tests for serodiagnosis of classical swine fever

2018 ◽  
Author(s):  
Aparajita Das ◽  
Dilip K. Bhattacharyya
Keyword(s):  
Indirect Elisa ◽  
Classical Swine Fever ◽  
Vertical Flow ◽  
Serum Samples ◽  
Specificity And Sensitivity ◽  
North Eastern ◽  
Rapid Tests ◽  
Flow Through ◽  
Dot Elisa ◽  
Elisa Titre

The present study was carried out to develop rapid field-based immunoassays for onsite detection of Classical swine fever virus (CSFV) antibody in clinical serum sample. Purified CSFV antigen was coated onto nitrocellulose membranes housed in a plastic module with layers of absorbent filter pads underneath. Following addition of serum to be tested appearance of a red dot indicated the presence of antibodies to CSF virus in the sample tested. A total of 240 serum samples collected from different areas of North Eastern States of India were tested for the presence of CSFV antibody by Indirect ELISA, Dot ELISA and Vertical flow through test. The result of the Indirect ELISA could be obtained within 2.5 hours whereas the result in case of Dot ELISA and Vertical Flow through test was obtained within 1 hour and 15 minutes respectively. Dot-ELISA and Vertical flow through test could equally detect the CSFV antibody in samples possessing 1:4 and above ELISA titre. The specificity and sensitivity of Dot-ELISA and vertical flow through test after comparison with Indirect ELISA indicated 100% specific and 84.28% sensitive. These tests have the potential to be used as a field-based kit to assess the serodiagnosis of CSFV.

scholarly journals Field Validation of the Use of RB51 as Antigen in a Complement Fixation Test To Identify Calves Vaccinated withBrucella abortus RB51

2001 ◽  
Vol 8 (2) ◽  
pp. 385-387 ◽  
Author(s):  
Rosanna Adone ◽  
Franco Ciuchini ◽  
Steven Olsen
Keyword(s):  
Complement Fixation ◽  
High Specificity ◽  
Antibody Responses ◽  
Test Results ◽  
Dot Blot ◽  
Serum Samples ◽  
Specificity And Sensitivity ◽  
Routine Surveillance ◽  
Dot Blot Assay ◽  
Smooth Strain

ABSTRACT In order to confirm the efficiency of an experimental RB51-based complement fixation (CF) test in identifying cattle vaccinated withBrucella abortus strain RB51, 831 sera from 110 vaccinated and 48 unvaccinated Hereford heifers of Iowa, collected for studies conducted in different years, were sent to Italy without coding to be tested in a CF test using RB51 as antigen. Most of the calves, aged from 3 to 10 months, were vaccinated subcutaneously with the recommended dosage of 1010 CFU of RB51 commercial vaccine, while only six calves received 109 CFU of the same vaccine. Serum samples for serologic testing, collected until 16 postinoculation weeks (PIW), were also tested by routine surveillance tests for brucellosis such as rose bengal plate and CF tests performed withB. abortus smooth strain 99 as control antigen. RB51 CF test results obtained by testing sera from cattle vaccinated in 1999 indicate that the sensitivity of the reaction is 97% at 2 to 3 PIW and 90% until 8 PIW and decreases to 65% at 12 PIW, the specificity remaining at 100%. Collectively, the results of this study confirm that serologic standard tests fail to detect antibodies to RB51 while the RB51-based CF test is able to monitor antibody responses to RB51 until 15 to 16 PIW with a specificity of 100%. In addition, unlike the RB51-based dot blot assay, which is the only test currently used to monitor antibody responses to RB51, the CF test also detected specific responses following vaccination with 109 CFU of RB51, although seroconversion was only 50% at 8 PIW. In conclusion, because of high specificity and sensitivity, the CF test described here can be used to efficaciously monitor serologic responses following RB51 vaccination in cattle and could also be employed to detect RB51 infection in humans exposed to this strain.

scholarly journals Production and Characterization of a Polyclonal Antibody of Anti-rLipL21-IgG againstLeptospirafor Early Detection of Acute Leptospirosis

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Arivudainambi Seenichamy ◽  
Abdul Rani Bahaman ◽  
Abdul Rahim Mutalib ◽  
Siti Khairani-Bejo
Keyword(s):  
Polyclonal Antibody ◽  
Diagnostic Marker ◽  
Bacterial Species ◽  
High Specificity ◽  
Cross Reactivity ◽  
Zoonotic Diseases ◽  
Igg Antibody ◽  
E Coli ◽  
Specificity And Sensitivity

Leptospirosis is one of the zoonotic diseases in animals and humans throughout the world. LipL21 is one of the important surface-exposed lipoproteins in leptospires and the most effective cross protective immunogenic antigen. It is widely considered as a diagnostic marker for leptospirosis. In this study, we evaluated the serodiagnostic potential of LipL21 protein ofLeptospira interrogansserovar Pomona. We have successfully amplified, cloned, and expressed LipL21 inE. coliand evaluated its specificity by immunoblotting. Purified recombinant LipL21 (rLipL21) was inoculated into rabbits for the production of polyclonal antibody. Characterization of the purified IgG antibody against rLipL21 was performed by cross reactivity assay. Only sera from leptospirosis patients and rabbit hyperimmune sera recognized rLipL21 while the nonleptospirosis control sera showed no reaction in immunoblotting. We confirmed that anti-rLipL21-IgG antibody cross reacted with and detected only pathogenic leptospiral species and it did not react with nonpathogenic leptospires and other bacterial species. Results observed showed that anti-rLipL21-IgG antibody has high specificity and sensitivity to leptospires. The findings indicated that the antibody could be used in a diagnostic assay for detection of leptospires or their proteins in the early phase of infection.

Sign in / Sign up

Export Citation Format

Share Document